NCT04678388

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

A Randomized, Open-label, Single Dose, Crossover Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers Under Fasting Conditions

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers under Fasting Conditions

Detailed description

A randomized, open-label, single dose, crossover study to investigate the pharmacokinetic profiles and safety of high-dose CKD-385 in healthy volunteers under fasting conditions

Conditions

• Cardiovascular Diseases

Interventions

Type	Name	Description
DRUG	Reference drug	1 Cap., single oral administration under fasting condition
DRUG	Test drug 1	1 Tab., single oral administration under fasting condition
DRUG	Test drug 2	1 Tab., single oral administration under fasting condition

Timeline

• Start date: 2020-10-29
• Primary completion: 2020-12-12
• Completion: 2020-12-12
• First posted: 2020-12-21
• Last updated: 2020-12-21

Locations

1 site across 1 country: South Korea